Dual carriers of HOXB13 rs138213197 T and CIP2A rs2278911 T, both of which are prostate cancer susceptibility variants, show the risk of prostate cancer with threefold higher odds than the HOXB13 T allele alone. This evidence concerns the gene CIP2A and prostate carcinoma.